OssDsign Catalyst® – Real World Data. Real World Results.™
A nanosynthetic™, silicate-substituted bone graft designed to upregulate cellular BMP-2, drive dual pathway healing, including endochondral ossification, and cell-mediated coupled remodeling, enabling rapid, robust fusion in challenging environments.
Nanosynthetic Bone Graft: Bridging Preclinical Strength and Real World Success
See the evidence behind Catalyst, from mechanistic preclinical data to real world clinical outcomes. This session walks through the science validating its dual pathway healing approach and the performance data supporting how that translates into rapid, robust fusion even in challenging cases.
This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.
Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.
